FDA Proposal For Increased Sunscreen Safety Testing On NDAC Agenda
This article was originally published in The Tan Sheet
Executive Summary
FDA’s Nonprescription Drug Advisory Committee will consider proposed tests for evaluating the safety of sunscreen ingredients that sponsors want to add to the OTC monograph. The committee will not consider the safety or efficacy of specific ingredients pending review via TEAs.